SGLT2

National Institute of Diabetes and Digestive and Kidney DiseasesUS$11.3mNational Heart, Lung, and Blood InstituteUS$3.4mNational Institute on AgingUS$1.2m

• Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using SGLT2 Inhibitors

  National Heart, Lung, and Blood InstituteUniversity of Illinois at ChicagoUS$755.9k2025–2030

• Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)

  National Institute of Diabetes and Digestive and Kidney DiseasesAdventhealth OrlandoUS$2.5m2025–2028

• Continuous ketone monitoring with the use of SGLT2 inhibitors in T1D

  National Institute of Diabetes and Digestive and Kidney DiseasesMcGill UniversityUS$123.3k2025–2029

• Cardiovascular and Renal Protection with SGLT2 Inhibition in Kidney Transplant Recipients (RENAISSANCE)

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of MinnesotaUS$380.5k2025–2027

• CHERISH (duCHennE caRdiomyopathy mItigation Sglt2 inHibitor)

  National Heart, Lung, and Blood InstituteIndiana University IndianapolisUS$444.8k2025–2026

• Effects of SGLT2 Inhibition on Coronary Flow Reserve and Other Key Indices Relevant to Type 2 Myocardial Infarction Risk among Women with HIV

  National Heart, Lung, and Blood InstituteMassachusetts General HospitalUS$752.6k2024–2029

• SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Texas Hlth Science CenterUS$674.2k1998–2027

• The Effect of SGLT2 Inhibition on Adipose Tissue Inflammation and Endothelial Function

  National Heart, Lung, and Blood InstituteVanderbilt University Medical CenterUS$185.4k2023–2028

• Elucidating Drug Interactomes for Cardiac Protection by SGLT2 Inhibitors

  National Heart, Lung, and Blood InstituteStanford UniversityUS$131.1k2025–2027

• SGLT2 inhibitors after acute kidney injury to improve outcomes in type 2 diabetes

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of MinnesotaUS$167k2025–2030